Nicotinamide N-Methyltransferase Remodeled Cell Metabolism and Aggravated Proinflammatory Responses by Activating STAT3/IL1β/PGE(2) Pathway.

Nicotinamide N-Methyltransferase Remodeled Cell Metabolism and Aggravated Proinflammatory Responses by Activating STAT3/IL1β/PGE(2) Pathway.
复制标题

烟酰胺 N-甲基转移酶通过激活 STAT3/IL1β/PGE2 途径重塑细胞代谢并加剧促炎反应

DOI:
10.1021/acsomega.2c04286
复制
发表时间:
2022-10-25
期刊:
影响因子:
4.1
通讯作者:
Deng, Haiteng
Deng, Haiteng
中科院分区:
化学3区
文献类型:
--
作者:
Yang, Changmei;Wang, Tianxiang;Zhu, Songbiao;Zong, Zhaoyun;Luo, Chengting;Zhao, Yujiao;Liu, Jing;Li, Ting;Liu, Xiaohui;Liu, Chongdong;Deng, Haiteng

文献摘要

参考文献

被引文献

相似文献

Nicotinamide N-methyltransferase (NNMT) is a cytosolic methyltransferase, catalyzing N-methylation of nicotinamide (NAM) to form 1-methylnicotinamide (1-MNAM), in which S-adenosyl-l-methionine (SAM) is the methyl donor. It has been well documented that NNMT is elevated in multiple cancers and promotes tumor aggressiveness. In the present study, we investigated the effects of NNMT overexpression on cellular metabolism and proinflammatory responses. We found that NNMT overexpression reduced NAD+ and SAM levels, and activated the STAT3 signaling pathway. Consequently, STAT3 activation upregulated interleukin 1β (IL1β) and cyclooxygenase-2 (COX2), leading to prostaglandin E2 (PGE2) accumulation. On the other hand, NNMT downregulated 15-hydroxyprostaglandin dehydrogenase (15-PGDH) which catalyzes PGE2 into inactive molecules. Moreover, secretomic data indicated that NNMT promoted secretion of collagens, pro-inflammatory cytokines, and extracellular matrix proteins, confirming NNMT aggravated inflammatory responses to promote cell growth, migration, epithelial-mesenchymal transition (EMT), and chemoresistance. Taken together, we showed that NNMT played a pro-inflammatory role in cancer cells by activating the STAT3/IL1β/PGE2 axis and proposed that NNMT was a potential therapeutic target for cancer treatment.
DOI: 10.1186/1741-7015-11-106
发表时间: 2013-04-16
期刊: BMC medicine
影响因子: 9.3
作者:
Hsu YC;Chen HY;Yuan S;Yu SL;Lin CH;Wu G;Yang PC;Li KC
通讯作者: Li KC
DOI: 10.1016/j.omtn.2018.03.011
发表时间: 2018-06-01
期刊: Molecular therapy. Nucleic acids
影响因子: --
作者:
Bach DH;Kim D;Bae SY;Kim WK;Hong JY;Lee HJ;Rajasekaran N;Kwon S;Fan Y;Luu TT;Shin YK;Lee J;Lee SK
通讯作者: Lee SK
CD38 的过度表达会降低细胞 NAD 水平并改变参与能量代谢和抗氧化防御的蛋白质的表达
DOI: 10.1021/pr4010597
发表时间: 2014-02-01
影响因子: 4.4
作者:
Hu, Yadong;Wang, Helin;Deng, Haiteng
通讯作者: Deng, Haiteng
DOI: 10.1038/nature13198
发表时间: 2014-04-10
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --
DOI: 10.1158/1078-0432.ccr-17-2289
发表时间: 2018-03-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Aisner DL;Sholl LM;Berry LD;Rossi MR;Chen H;Fujimoto J;Moreira AL;Ramalingam SS;Villaruz LC;Otterson GA;Haura E;Politi K;Glisson B;Cetnar J;Garon EB;Schiller J;Waqar SN;Sequist LV;Brahmer J;Shyr Y;Kugler K;Wistuba II;Johnson BE;Minna JD;Kris MG;Bunn PA;Kwiatkowski DJ;LCMC2 investigators
通讯作者: LCMC2 investigators